HEALTHPEAK PROPERTIES INC (PEAK) Fundamental Analysis & Valuation

NYSE:PEAK • US42250P1030

Current stock price

17.1 USD
+0.35 (+2.09%)
At close:
17.1 USD
0 (0%)
After Hours:

This PEAK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. PEAK Profitability Analysis

1.1 Basic Checks

  • In the past year PEAK was profitable.
  • PEAK had a positive operating cash flow in the past year.
  • In the past 5 years PEAK has always been profitable.
  • In the past 5 years PEAK always reported a positive cash flow from operatings.
PEAK Yearly Net Income VS EBIT VS OCF VS FCFPEAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B -1B

1.2 Ratios

  • The Return On Assets of PEAK (1.94%) is better than 65.60% of its industry peers.
  • With a decent Return On Equity value of 4.79%, PEAK is doing good in the industry, outperforming 68.80% of the companies in the same industry.
  • PEAK has a Return On Invested Capital (2.45%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for PEAK is in line with the industry average of 3.11%.
  • The 3 year average ROIC (2.14%) for PEAK is below the current ROIC(2.45%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.94%
ROE 4.79%
ROIC 2.45%
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%
PEAK Yearly ROA, ROE, ROICPEAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

  • The Profit Margin of PEAK (13.95%) is better than 68.00% of its industry peers.
  • In the last couple of years the Profit Margin of PEAK has declined.
  • PEAK has a Operating Margin (20.53%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of PEAK has declined.
  • PEAK's Gross Margin of 59.28% is on the low side compared to the rest of the industry. PEAK is outperformed by 73.60% of its industry peers.
  • In the last couple of years the Gross Margin of PEAK has declined.
Industry RankSector Rank
OM 20.53%
PM (TTM) 13.95%
GM 59.28%
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%
PEAK Yearly Profit, Operating, Gross MarginsPEAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

1

2. PEAK Health Analysis

2.1 Basic Checks

  • PEAK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for PEAK remains at a similar level compared to 1 year ago.
  • PEAK has a worse debt/assets ratio than last year.
PEAK Yearly Shares OutstandingPEAK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
PEAK Yearly Total Debt VS Total AssetsPEAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

  • PEAK has an Altman-Z score of 0.34. This is a bad value and indicates that PEAK is not financially healthy and even has some risk of bankruptcy.
  • PEAK has a worse Altman-Z score (0.34) than 64.80% of its industry peers.
  • PEAK has a debt to FCF ratio of 32.87. This is a negative value and a sign of low solvency as PEAK would need 32.87 years to pay back of all of its debts.
  • PEAK has a Debt to FCF ratio (32.87) which is in line with its industry peers.
  • PEAK has a Debt/Equity ratio of 1.08. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of PEAK (1.08) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 32.87
Altman-Z 0.34
ROIC/WACC0.37
WACC6.55%
PEAK Yearly LT Debt VS Equity VS FCFPEAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B

2.3 Liquidity

  • PEAK has a Current Ratio of 0.14. This is a bad value and indicates that PEAK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of PEAK (0.14) is worse than 96.80% of its industry peers.
  • A Quick Ratio of 0.14 indicates that PEAK may have some problems paying its short term obligations.
  • PEAK has a Quick ratio of 0.14. This is amonst the worse of the industry: PEAK underperforms 96.80% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14
PEAK Yearly Current Assets VS Current LiabilitesPEAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

4

3. PEAK Growth Analysis

3.1 Past

  • The earnings per share for PEAK have decreased strongly by -38.86% in the last year.
  • Measured over the past years, PEAK shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -23.30% on average per year.
  • The Revenue has been growing slightly by 5.81% in the past year.
  • Measured over the past years, PEAK shows a quite strong growth in Revenue. The Revenue has been growing by 12.86% on average per year.
EPS 1Y (TTM)-38.86%
EPS 3Y-12.64%
EPS 5Y-23.3%
EPS Q2Q%1200%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%5.56%

3.2 Future

  • Based on estimates for the next years, PEAK will show a decrease in Earnings Per Share. The EPS will decrease by -3.48% on average per year.
  • The Revenue is expected to grow by 8.55% on average over the next years. This is quite good.
EPS Next Y-30.18%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%
EPS Next 5Y-3.48%
Revenue Next Year15.38%
Revenue Next 2Y10.7%
Revenue Next 3Y8.55%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PEAK Yearly Revenue VS EstimatesPEAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
PEAK Yearly EPS VS EstimatesPEAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

2

4. PEAK Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 30.54, the valuation of PEAK can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of PEAK indicates a somewhat cheap valuation: PEAK is cheaper than 61.60% of the companies listed in the same industry.
  • PEAK is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.71, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 43.73, which means the current valuation is very expensive for PEAK.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PEAK indicates a somewhat cheap valuation: PEAK is cheaper than 65.60% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.83, PEAK is valued quite expensively.
Industry RankSector Rank
PE 30.54
Fwd PE 43.73
PEAK Price Earnings VS Forward Price EarningsPEAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 62.40% of the companies in the same industry are more expensive than PEAK, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PEAK is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 44.73
EV/EBITDA 13.46
PEAK Per share dataPEAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • A cheap valuation may be justified as PEAK's earnings are expected to decrease with -5.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%

5

5. PEAK Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 7.02%, PEAK is a good candidate for dividend investing.
  • PEAK's Dividend Yield is a higher than the industry average which is at 7.30.
  • Compared to an average S&P500 Dividend Yield of 1.91, PEAK pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.02%

5.2 History

  • The dividend of PEAK decreases each year by -11.76%.
  • PEAK has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-11.76%
Div Incr Years0
Div Non Decr Years0
PEAK Yearly Dividends per sharePEAK Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2

5.3 Sustainability

  • PEAK pays out 215.92% of its income as dividend. This is not a sustainable payout ratio.
  • PEAK's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP215.92%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%
PEAK Yearly Income VS Free CF VS DividendPEAK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B -1B
PEAK Dividend Payout.PEAK Dividend Payout, showing the Payout Ratio.PEAK Dividend Payout.PayoutRetained Earnings

PEAK Fundamentals: All Metrics, Ratios and Statistics

HEALTHPEAK PROPERTIES INC

NYSE:PEAK (3/1/2024, 8:04:00 PM)

After market: 17.1 0 (0%)

17.1

+0.35 (+2.09%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-08
Earnings (Next)N/A
Inst Owners117.78%
Inst Owner Change-1.11%
Ins Owners0.15%
Ins Owner Change0%
Market Cap9.36B
Revenue(TTM)2.18B
Net Income(TTM)304.29M
Analysts78.18
Price Target22.19 (29.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.02%
Yearly Dividend1.2
Dividend Growth(5Y)-11.76%
DP215.92%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.48%
Min EPS beat(2)25.88%
Max EPS beat(2)43.09%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-17.64%
Max EPS beat(4)149.96%
EPS beat(8)6
Avg EPS beat(8)80.62%
EPS beat(12)9
Avg EPS beat(12)65.46%
EPS beat(16)12
Avg EPS beat(16)81.29%
Revenue beat(2)1
Avg Revenue beat(2)-0.5%
Min Revenue beat(2)-1.62%
Max Revenue beat(2)0.62%
Revenue beat(4)1
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-1.62%
Max Revenue beat(4)0.62%
Revenue beat(8)2
Avg Revenue beat(8)-0.54%
Revenue beat(12)3
Avg Revenue beat(12)-1.7%
Revenue beat(16)3
Avg Revenue beat(16)-8.89%
PT rev (1m)-1.34%
PT rev (3m)2.46%
EPS NQ rev (1m)-15.62%
EPS NQ rev (3m)-7.95%
EPS NY rev (1m)-12.55%
EPS NY rev (3m)-6.5%
Revenue NQ rev (1m)-1.28%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)6.65%
Revenue NY rev (3m)16.7%
Valuation
Industry RankSector Rank
PE 30.54
Fwd PE 43.73
P/S 4.29
P/FCF 44.73
P/OCF 9.78
P/B 1.47
P/tB 1.55
EV/EBITDA 13.46
EPS(TTM)0.56
EY3.27%
EPS(NY)0.39
Fwd EY2.29%
FCF(TTM)0.38
FCFY2.24%
OCF(TTM)1.75
OCFY10.22%
SpS3.99
BVpS11.61
TBVpS11.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.94%
ROE 4.79%
ROCE 3.1%
ROIC 2.45%
ROICexc 2.47%
ROICexgc 2.68%
OM 20.53%
PM (TTM) 13.95%
GM 59.28%
FCFM 9.59%
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%
ROICexc(3y)2.16%
ROICexc(5y)1.9%
ROICexgc(3y)2.33%
ROICexgc(5y)2.05%
ROCE(3y)2.71%
ROCE(5y)2.39%
ROICexgc growth 3Y28.26%
ROICexgc growth 5Y4.6%
ROICexc growth 3Y28.51%
ROICexc growth 5Y3.28%
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%
F-Score6
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 32.87
Debt/EBITDA 5.74
Cap/Depr 99.62%
Cap/Sales 34.25%
Interest Coverage 2.38
Cash Conversion 79.85%
Profit Quality 68.75%
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z 0.34
F-Score6
WACC6.55%
ROIC/WACC0.37
Cap/Depr(3y)183.97%
Cap/Depr(5y)234.29%
Cap/Sales(3y)65.04%
Cap/Sales(5y)98.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.86%
EPS 3Y-12.64%
EPS 5Y-23.3%
EPS Q2Q%1200%
EPS Next Y-30.18%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%
EPS Next 5Y-3.48%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%5.56%
Revenue Next Year15.38%
Revenue Next 2Y10.7%
Revenue Next 3Y8.55%
Revenue Next 5YN/A
EBIT growth 1Y13.63%
EBIT growth 3Y27.09%
EBIT growth 5Y6.6%
EBIT Next Year208.15%
EBIT Next 3Y49.06%
EBIT Next 5Y31.97%
FCF growth 1Y249.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.21%
OCF growth 3Y8.03%
OCF growth 5Y2.41%

HEALTHPEAK PROPERTIES INC / PEAK Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to PEAK.


What is the valuation status of HEALTHPEAK PROPERTIES INC (PEAK) stock?

ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (PEAK). This can be considered as Overvalued.


What is the profitability of PEAK stock?

HEALTHPEAK PROPERTIES INC (PEAK) has a profitability rating of 5 / 10.


What is the earnings growth outlook for HEALTHPEAK PROPERTIES INC?

The Earnings per Share (EPS) of HEALTHPEAK PROPERTIES INC (PEAK) is expected to decline by -30.18% in the next year.


Is the dividend of HEALTHPEAK PROPERTIES INC sustainable?

The dividend rating of HEALTHPEAK PROPERTIES INC (PEAK) is 5 / 10 and the dividend payout ratio is 215.92%.